The use of cost-benefit analysis to evaluate the wisdom of lifesaving regulatory programs presents a puzzle. Deciding to allow one person to harm, even to kill, another person on the basis of how much it costs the person doing the harm to refrain from doing it denies the person harmed a right against harm. It makes a person 's freedom from harm, indeed her life, contingent upon the financial profile of the lifethreatening activity.